Jul 27, 2021 7:30am EDT Rigel Announces Conference Call and Webcast to Report Second Quarter 2021 Financial Results and Business Update
Jul 14, 2021 7:30am EDT New TAVALISSE® Data Analyses To Be Presented at International Society on Thrombosis and Haemostasis (ISTH) 2021 Congress
May 05, 2021 4:01pm EDT Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
Apr 28, 2021 7:30am EDT Rigel Announces Conference Call and Webcast to Report First Quarter 2021 Financial Results and Business Update
Apr 13, 2021 7:00am EDT Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19
Mar 11, 2021 7:30am EST Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
